|
1 |
Creative Commons |
CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade |
A conversation with Ben Fairfax about the recent article: CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade. |
Ben Fairfax, Paul Klenerman |
13 Jun 2025 |
|
2 |
Creative Commons |
Getting the dose right |
Too high a dose can result in toxicity and side-effects, too low a dose can cause the illness to come back and at worse develop resistance. |
Joel Tarning |
28 Jul 2015 |
|
3 |
Creative Commons |
Getting the dose right |
Too high a dose can result in toxicity and side-effects, too low a dose can cause the illness to come back and at worse develop resistance. |
Joel Tarning |
28 Jul 2015 |
